The HNCIG Board of Directors met alongside the ESMO meeting in Vienna on September 25, 2015.
Category: Meetings
Board Meeting February 2015
The initial meeting of the HNCIG took place on February 12, 2015 in Nice, France alongside the fourth International Conference on Innovative Approaches in Head and Neck Oncology.
Documents
- Presentations
- Clinical Trial Concepts
- HN1436, Post-Operative Concurrent EGFR Inhibition
with Afatinib and Radiation Versus Post-
Operative Radiotherapy Alone in High Risk
Cutaneous Squamous Cell Carcinoma of the
Head and Neck - CompARE, Comparing Alternative treatment Regimens for
intermediate and high risk oropharyngeal cancer
CompARE - JCOG 1008, Phase II/III Trial of Postoperative Chemoradiotherapy
Comparing 3-Weekly Cisplatin with Weekly Cisplatin
in High-risk Patients with SCCHN
- HN1436, Post-Operative Concurrent EGFR Inhibition
- Minutes